No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
475 |
4. Check minimum number of eventsNone |
475 |
5. Include endpointsNone |
475 |
6. Filter based on genotype QC (FinnGen only) |
475 |
Control definitions (FinnGen only)
- Control exclude
- M13_ARTHROPATHIES
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M24
- Name in latin
- Contractura articulationis
Similar endpoints
↥List of similar endpoints to
Contracture of joint
based on the number of shared cases.
Similar with more cases:
- Other joint disorders
- Arthropathies
- Diseases of the musculoskeletal system and connective tissue
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 4443 | 2087 | 2306 |
| Only index persons | 3699 | 1819 | 1880 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.06 | 0.06 | 0.06 |
| Only index persons | 0.07 | 0.07 | 0.07 |
| Median age at first event (years) | |||
| Whole population | 50.49 | 51.25 | 49.64 |
| Only index persons | 48.48 | 50.18 | 46.83 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 475 | 249 | 226 |
| Unadjusted period prevalence (%) | 0.09 | 0.08 | 0.10 |
| Median age at first event (years) | 49.62 | 47.23 | 52.26 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 423
- Matched controls
- 4231
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M24.5
ICD-10 Finland
Contracture of joint
+∞
323.0
280
*
72900
ICD-8 Finland
Other diseases of joint, Contractura articuli
+∞
93.2
86
*
M17.1
ICD-10 Finland
Other primary gonarthrosis
30.6
82.8
112
49
M19.0
ICD-10 Finland
Primary arthrosis of other joints
69.5
61.8
70
12
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
+∞
55.4
52
*
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
42.1
42.0
52
14
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
16.9
40.1
65
45
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
116.2
39.5
42
*
ZXA05
NOMESCO Finland
Left side
4.7
37.1
153
456
M25.5
ICD-10 Finland
Pain in joint
5.3
37.0
129
321
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
376.7
35.5
35
*
ZXA00
NOMESCO Finland
Right side
4.0
30.8
151
515
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
10.8
29.5
58
61
N02AX02
ATC
tramadol; systemic, rectal
3.3
29.1
205
927
M16.1
ICD-10 Finland
Other primary coxarthrosis
39.6
26.5
33
9
X59
ICD-10 Finland
Exposure to unspecified factor
4.3
26.1
108
309
NGT60
NOMESCO Finland
Forcible manipulation of knee joint
276.4
26.0
26
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
3.1
26.0
209
1014
NGB40
NOMESCO Finland
Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis
+∞
24.2
23
*
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
8.6
23.1
51
66
NBT60
NOMESCO Finland
Forcible manipulation of humeroscapular joint
18.9
23.0
35
20
1220
FHL
Arthroscopy
19.7
22.1
33
18
72410
ICD-8 Finland
Internal derangement of joint, Other shoulder derangement
+∞
22.1
21
*
M75.1
ICD-10 Finland
Rotator cuff syndrome
3.4
20.6
116
423
R4110
NOMESCO Finland
Physiotherapy
3.1
20.4
137
563
NDE60
NOMESCO Finland
Incision and release of adhesions in joint of finger or metacarpal
+∞
19.9
19
*
M17.3
ICD-10 Finland
Other post-traumatic gonarthrosis
+∞
19.9
19
*
WX320
NOMESCO Finland
Spinalanesthesy
3.8
19.9
94
297
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.9
19.4
145
638
S18
ICPC
Laceration/cut
2.7
19.3
179
902
M01AX05
ATC
glucosamine; oral
4.2
19.1
79
221
N02BE01
ATC
paracetamol; systemic, rectal
3.1
18.7
356
2678
M75.0
ICD-10 Finland
Adhesive capsulitis of shoulder
6.6
18.7
49
82
N03AX16
ATC
pregabalin; oral
3.2
18.6
111
418
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
8.2
18.6
42
56
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
8.7
18.0
39
49
B01AB05
ATC
enoxaparin; parenteral
2.9
17.8
130
558
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
30.3
17.6
23
8
L90
ICPC
Osteoarthrosis of knee
14.1
17.2
29
22
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
6.7
16.7
43
70
M19.1
ICD-10 Finland
Post-traumatic arthrosis of other joints
176.6
16.6
17
*
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
176.6
16.6
17
*
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
7.2
16.5
40
60
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
12.4
16.3
29
25
M16.0
ICD-10 Finland
Primary coxarthrosis, bilateral
19.5
16.2
24
13
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
34.8
15.9
20
6
Z96.6
ICD-10 Finland
Presence of orthopaedic joint implants
165.8
15.6
16
*
M79.6
ICD-10 Finland
Pain in limb
2.6
15.3
142
697
M01AH05
ATC
etoricoxib; oral
2.3
15.2
223
1376
R4120
NOMESCO Finland
Occupational therapy
5.9
15.1
43
80
M72.0
ICD-10 Finland
Palmar fascial fibromatosis [Dupuytren]
6.6
15.1
39
64
NCF25
NOMESCO Finland
Operation for osteochondritis of elbow joint, arthroscopic
58.8
14.9
17
*
NFB30
NOMESCO Finland
Primary total prosthetic replacement of hip joint not using cement
83.0
14.7
16
*
7184D
ICD-9 Finland
Other derangement of joint, Contracture of joint[CONTRACTURA, KÄSI]
+∞
14.7
14
*
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
6.1
14.6
40
71
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
5.8
14.3
41
77
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
4.1
14.0
56
151
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.8
13.9
101
423
L15
ICPC
Knee symptom/complaint
3.2
13.9
78
277
7184F
ICD-9 Finland
Other derangement of joint, Contracture of joint[CONTRACTURA, POLVI]
+∞
13.6
13
*
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
5.7
13.5
39
74
M17.5
ICD-10 Finland
Other secondary gonarthrosis
144.3
13.5
14
*
M13.9
ICD-10 Finland
Arthritis, unspecified
9.5
13.4
27
30
N02AJ06
ATC
codeine and paracetamol; systemic
2.4
13.2
134
681
NDM10
NOMESCO Finland
Palmar fasciotomy of hand
8.5
13.0
28
35
X58
ICD-10 Finland
Exposure to other specified factors
3.4
13.0
67
223
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
51.6
12.9
15
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.4
12.7
125
623
7151F
ICD-9 Finland
Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]
+∞
12.6
12
*
M23.8
ICD-10 Finland
Other internal derangements of knee
18.7
12.1
18
10
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.4
12.1
44
108
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
4.9
12.1
40
89
9253
FHL
Manipulation under anesthesia or regression and plastering
22.0
12.1
17
8
WX702
NOMESCO Finland
Supraglottic ventilation device
5.0
12.0
38
81
NBE15
NOMESCO Finland
Incision or suture of capsule of joint of shoulder, arthroscopic
48.1
11.9
14
*
M20.1
ICD-10 Finland
Hallux valgus (acquired)
11.0
11.9
22
21
NDU20
NOMESCO Finland
Removal of internal fixation device from wrist or hand
15.2
11.9
19
13
L28
ICPC
Limited function/disability (L)
3.2
11.7
64
221
NG1DA
NOMESCO Finland
X-ray of knees
+∞
11.5
11
*
NDL54
NOMESCO Finland
Tenolysis of hand
+∞
11.5
11
*
7184E
ICD-9 Finland
Other derangement of joint, Contracture of joint[CONTRACTURA, LONKKANIVEL]
+∞
11.5
11
*
WX200
NOMESCO Finland
Interscalenous plexus blockade
12.3
11.4
20
17
M01AB05
ATC
diclofenac; systemic, rectal
2.1
11.4
264
1891
G56.2
ICD-10 Finland
Lesion of ulnar nerve
11.0
11.4
21
20
M09AX01
ATC
hyaluronic acid; parenteral
10.0
11.4
22
23
J01DA01
ATC
[U] cefalexin; systemic
2.0
11.0
261
1876
M22.4
ICD-10 Finland
Chondromalacia patellae
44.5
11.0
13
*
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
11.0
10.9
20
19
WX110
NOMESCO Finland
Local anesthesy
2.0
10.6
272
2000
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
3.0
10.6
65
244
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.1
10.6
153
896
S83.6
ICD-10 Finland
Sprain and strain of other and unspecified parts of knee
7.1
10.5
25
37
WX203
NOMESCO Finland
Infraclavicular plexus blockade
9.9
10.4
20
21
M01AE03
ATC
ketoprofen; systemic, rectal
2.1
10.3
158
947
H02AB06
ATC
prednisolone; systemic
2.0
10.3
177
1110
N03AX12
ATC
gabapentin; oral
3.0
10.2
61
223
P01BA02
ATC
hydroxychloroquine; oral
6.1
10.1
27
47
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.1
10.0
142
823
S62.6
ICD-10 Finland
Fracture of other finger
5.1
10.0
31
65
J01FF01
ATC
clindamycin; systemic
2.3
10.0
109
563
M01AC06
ATC
meloxicam; systemic, rectal
2.1
9.9
136
773
M54.5
ICD-10 Finland
Low back pain
2.1
9.8
129
724
B01AF01
ATC
rivaroxaban; oral
4.0
9.7
38
101
NGF35
NOMESCO Finland
Plastic operation of joint cartilage of knee
15.5
9.6
15
10
NHG80
NOMESCO Finland
Fusion of first tarsometatarsal joint
102.2
9.4
10
*
WX111
NOMESCO Finland
Local infiltration anesthesia
102.2
9.4
10
*
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
8.3
9.4
20
25
WX002
NOMESCO Finland
Sedation and analgesia
2.5
9.4
77
343
71301
ICD-8 Finland
Osteo-arthritis and allied conditions, Arthritis (arthrosis) genus
+∞
9.4
9
*
A02BC02
ATC
pantoprazole; systemic
1.9
9.4
249
1812
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.2
9.3
50
172
A07EC01
ATC
sulfasalazine; oral, rectal
5.7
9.0
25
46
L08
ICPC
Shoulder symptom/complaint
2.5
9.0
72
316
S83.2
ICD-10 Finland
Tear of meniscus, current
4.4
8.9
31
74
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.5
8.8
71
313
NBG00
NOMESCO Finland
Plastic operation on acromioclavicular joint
51.0
8.7
10
*
T84.5
ICD-10 Finland
Infection and inflammatory reaction due to internal joint prosthesis
51.0
8.7
10
*
NHU20
NOMESCO Finland
Removal of internal fixation device from ankle or foot
7.6
8.5
19
26
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
8.5
108
589
G56.0
ICD-10 Finland
Carpal tunnel syndrome
3.0
8.5
50
183
NGF15
NOMESCO Finland
Total synovectomy of knee, arthroscopic
91.8
8.4
9
*
M01AH01
ATC
celecoxib; oral (coxibs)
2.5
8.4
66
287
NHG76
NOMESCO Finland
Arthroplasty of other tarsometatarsal joint
+∞
8.4
8
*
M24.4
ICD-10 Finland
Recurrent dislocation and subluxation of joint
+∞
8.4
8
*
ND1AA
NOMESCO Finland
Wrist X-ray examination
4.4
8.3
29
70
S83.5
ICD-10 Finland
Sprain and strain involving (anterior)(posterior) cruciate ligament of knee
6.3
8.2
21
35
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
7.8
8.2
18
24
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
7.8
8.2
18
24
Z50.1
ICD-10 Finland
Other physical therapy
4.7
8.2
27
61
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
5.0
8.2
25
52
J01DB01
ATC
cefalexin; oral
1.9
8.1
320
2606
R07.4
ICD-10 Finland
Chest pain, unspecified
2.1
8.1
102
555
A04
ICPC
Weakness/tiredness general
2.8
8.1
54
213
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
5.7
8.1
22
40
WX212
NOMESCO Finland
Femoral plexus blockade
10.3
8.1
15
15
M01AE02
ATC
naproxen; oral, rectal
1.8
8.0
212
1509
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
4.4
7.9
27
64
M01AH02
ATC
rofecoxib; oral
2.9
7.8
48
180
1225
FHL
Arthroscopy and other therapeutic procedure
45.8
7.7
9
*
J01AA02
ATC
doxycycline; systemic
1.9
7.7
309
2504
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
3.3
7.7
37
118
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
18.8
7.6
11
6
TNX32
NOMESCO Finland
Custom moulded splint, unspecified region
4.6
7.6
25
57
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
7.6
155
1011
J01MA02
ATC
ciprofloxacin; systemic
1.8
7.4
149
963
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
3.5
7.3
33
100
M79.0
ICD-10 Finland
Rheumatism, unspecified
6.4
7.3
18
29
M19.2
ICD-10 Finland
Other secondary arthrosis
+∞
7.3
7
*
7184A
ICD-9 Finland
Other derangement of joint, Contracture of joint[CONTRACTURA, OLKANIVEL]
+∞
7.3
7
*
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
+∞
7.3
7
*
1222
FHL
Arthroscopy and synovial surgery
+∞
7.3
7
*
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
+∞
7.3
7
*
M01AE01
ATC
ibuprofen; systemic, rectal
2.0
7.2
351
3001
NBE45
NOMESCO Finland
Plastic repair of ligament of shoulder not using prosthetic material, arthroscopic
30.6
7.2
9
*
M01AX17
ATC
nimesulide; oral
2.1
7.1
90
489
S83.0
ICD-10 Finland
Dislocation of patella
12.3
7.1
12
10
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.4
7.1
33
103
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
10.3
7.1
13
13
M19.8
ICD-10 Finland
Other specified arthrosis
7.2
7.1
16
23
W19
ICD-10 Finland
Unspecified fall
2.8
7.0
44
166
NGE35
NOMESCO Finland
Plastic repair of ligament of knee not using prosthetic material, anterior cruciate, arthroscopic
7.7
7.0
15
20
M25.4
ICD-10 Finland
Effusion of joint
14.1
6.9
11
8
SPAT1153
SPAT
Removal of sutures
1.9
6.8
111
661
M25.6
ICD-10 Finland
Stiffness of joint, not elsewhere classified
40.7
6.8
8
*
M15.0
ICD-10 Finland
Primary generalized (osteo)arthrosis
17.0
6.8
10
6
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.4
6.8
56
251
M24.2
ICD-10 Finland
Disorder of ligament
22.9
6.7
9
*
S30.0
ICD-10 Finland
Contusion of lower back and pelvis
5.6
6.7
18
33
M16.9
ICD-10 Finland
Coxarthrosis, unspecified
6.1
6.7
17
29
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.7
6.6
203
1480
NBF25
NOMESCO Finland
Operation for humeroscapular osteochondritis, arthroscopic
8.9
6.6
13
15
NF1AA
NOMESCO Finland
Hip X-ray examination
4.0
6.5
24
62
C03CA01
ATC
furosemide; systemic
1.9
6.5
107
643
SPAT1229
SPAT
Assessment of need for aid
3.4
6.5
30
94
M22.0
ICD-10 Finland
Recurrent dislocation of patella
70.8
6.4
7
*
NHK30
NOMESCO Finland
Osteotomy or rotation osteotomy of first metatarsal or tarsal bone
70.8
6.4
7
*
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
70.8
6.4
7
*
L04AA13
ATC
leflunomide; oral
70.8
6.4
7
*
NHG77
NOMESCO Finland
Arthroplasty of interphalangeal tarsal joint(s)
70.8
6.4
7
*
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
3.6
6.4
27
78
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.5
6.4
50
215
NB1CG
NOMESCO Finland
Shoulder and humerus extensive MRI examination with high intensity magnet
8.3
6.4
13
16
E66.01
ICD-10 Finland
Obesity due to excess calories
3.3
6.3
30
96
SAA01
NOMESCO Finland
Simple examination of mouth
1.7
6.3
257
2024
N06AX21
ATC
duloxetine; oral
2.8
6.3
40
154
7177A
ICD-9 Finland
Internal derangement of knee, Chondromalacia of patella
+∞
6.3
6
*
NGH99
NOMESCO Finland
Other operation on knee joint, unspecified
+∞
6.3
6
*
M00.9
ICD-10 Finland
Pyogenic arthritis, unspecified
+∞
6.3
6
*
NGE10
NOMESCO Finland
Incision or suture of capsule of knee joint
+∞
6.3
6
*
NGE60
NOMESCO Finland
Plastic repair of patellar ligaments, open
+∞
6.3
6
*
M25.2
ICD-10 Finland
Flail joint
+∞
6.3
6
*
7184B
ICD-9 Finland
Other derangement of joint, Contracture of joint[CONTRACTURA, KYYNÄRNIVEL]
+∞
6.3
6
*
T92.1
ICD-10 Finland
Sequelae of fracture of arm
27.1
6.2
8
*
M65.3
ICD-10 Finland
Trigger finger
4.6
6.2
20
45
L84
ICD-10 Finland
Corns and callosities
5.5
6.2
17
32
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.7
6.2
178
1269
R52.9
ICD-10 Finland
Pain, unspecified
3.1
6.2
32
109
E883A
ICD-9 Finland
Fall into hole or other opening in surface
3.6
6.1
26
76
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
5.0
6.1
18
37
M67.8
ICD-10 Finland
Other specified disorders of synovium and tendon
12.8
6.1
10
8
L12
ICPC
Hand/finger symptom/complaint
2.5
6.1
48
208
A02BC05
ATC
esomeprazole; systemic
1.7
6.1
145
976
N06AA09
ATC
amitriptyline; systemic
2.7
6.0
40
159
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3013707) Erythrocyte sedimentation rate by Westergren method
333
2413
2.27
14.85
4.5
3.2
mm/h
12.5
11.6
0.47
318
2201
(3042936) Bacteria identified in Isolate by Culture
86
411
2.33
10.43
2.3
1.9
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
87
424
2.29
10.06
1.4
1.2
iu/ml
409.3
14.6
0.50
27
131
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
82
392
2.32
9.91
1.4
1.1
u/ml
1.9
1.3
0.40
23
172
(3000475) Leukocytes [#/volume] in Synovial fluid
15
22
7.01
9.78
1.5
1.1
e6/l
2490.3
11186.2
—
9
16
(3024561) Albumin [Mass/volume] in Serum or Plasma
207
1402
1.84
9.47
3.7
4.7
g/l
35.3
35.5
0.15
198
1309
(3026493) Urate [Moles/volume] in Serum or Plasma
130
759
1.98
9.34
2.6
2.2
umol/l
6969.5
9078.9
0.17
112
656
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
338
2671
1.92
9.32
7.2
6.9
u/l
80.4
78.5
0.33
327
2509
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
213
1477
1.80
8.85
4.1
3.9
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
71
341
2.27
8.44
1.3
1.2
titre
660.0
382.0
0.29
12
60
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
15
26
5.92
8.37
1.3
1.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
133
809
1.89
8.35
4.9
6.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
19
42
4.67
8.19
1.7
1.9
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
173
1155
1.78
7.98
3.5
3.3
e6/l
105.2
120.5
0.10
123
818
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
119
708
1.91
7.95
1.6
1.5
mg/l
1.3
1.3
0.00
88
530
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
112
658
1.92
7.75
4.1
3.7
ng/l
176.4
436.3
1.07
81
495
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
406
3512
2.07
7.37
17.5
12.5
mg/l
24.7
25.8
0.26
346
2686
(3030467) Casts [#/volume] in Urine by Automated count
140
896
1.80
7.35
3.1
2.8
e6/l
0.4
0.5
0.50
107
655
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
95
538
1.96
7.30
2.7
2.5
e6/l
1.0
1.1
0.16
61
286
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
63
309
2.20
7.10
3.3
2.2
u/l
37.9
39.4
0.07
51
256
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
222
1637
1.67
6.88
6.5
6.6
mmol/l
1.2
1.2
0.23
197
1378
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
185
1301
1.69
6.87
2.2
1.9
pmol/l
97.2
94.8
0.32
107
682
(3002582) Erythrocytes [#/volume] in Urine
151
1010
1.73
6.71
3.2
2.9
e6/l
17.9
61.0
2.73
116
765
(3037467) Urinalysis macro (dipstick) panel - Urine
292
2323
1.67
6.64
4.6
3.7
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
11
9
12.47
6.61
1.3
1.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
133
868
1.74
6.41
3.0
2.8
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
203
1483
1.64
6.39
6.6
5.7
mmol/l
1.2
1.2
0.33
195
1345
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
90
523
1.89
6.36
2.8
2.6
e6/l
2.3
2.3
0.01
56
275
(3018418) pH of Serum or Plasma
143
956
1.71
6.31
4.0
3.8
ph
7.4
7.4
1.08
19
184
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
145
977
1.70
6.20
2.2
2.1
u/l
135.0
306.8
1.50
136
916
(3013650) Neutrophils [#/volume] in Blood by Automated count
250
1944
1.60
5.97
6.5
9.0
e9/l
4.2
4.1
0.18
220
1679
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
15
37
4.15
5.67
1.7
1.3
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
221
1686
1.58
5.61
4.8
5.4
e9/l
0.2
0.2
0.66
202
1461
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
168
1202
1.62
5.58
3.3
2.9
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
212
1614
1.57
5.36
4.6
5.0
e9/l
0.6
0.6
0.16
192
1377
(3044889) 12 lead EKG panel
302
2491
1.58
5.36
4.2
3.6
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
180
1320
1.59
5.35
2.4
2.2
nmol/l
77.4
75.6
0.33
164
1184
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
231
1798
1.55
5.26
5.5
6.4
umol/l
11.4
12.7
0.78
222
1715
(3006315) Basophils [#/volume] in Blood
212
1620
1.56
5.24
4.7
5.0
e9/l
0.0
0.0
0.18
194
1388
(3007853) Bacteria identified in Skin by Aerobe culture
64
355
1.93
5.17
2.1
1.6
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
215
1664
1.53
4.93
4.9
5.0
e9/l
1.8
2.0
1.12
194
1443
(3052851) Hemolysis interference index of Serum or Plasma
23
84
2.83
4.85
2.9
2.9
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
67
387
1.85
4.79
3.1
2.8
umol/l
5.1
9.5
2.05
60
343
(3011397) Hemoglobin [Presence] in Urine by Test strip
107
708
1.66
4.76
4.0
3.4
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
71
419
1.82
4.74
2.5
2.2
g/l
2.3
2.3
0.05
66
392
(3002385) Erythrocyte distribution width [Ratio]
348
3005
1.59
4.74
19.1
15.4
%
13.8
13.6
1.03
342
2933
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
150
1082
1.56
4.67
3.0
2.4
u/l
73.5
56.9
0.38
142
1003
(3012516) Albumin [Mass/volume] in Urine
137
974
1.57
4.53
3.5
3.2
mg/l
466.9
320.3
0.13
97
619
(3026008) Bacteria identified in Urine by Culture
137
975
1.57
4.50
3.7
3.0
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
145
1046
1.56
4.49
3.4
3.1
mmol/l
7.1
7.5
0.56
127
892
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
287
2390
1.51
4.48
3.3
3.0
u/l
56.6
48.9
0.50
273
2242
(3044640) Blood type and Crossmatch panel - Blood
142
1021
1.56
4.46
2.7
2.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
96
629
1.66
4.42
1.3
1.4
g/l
2.8
2.5
0.55
61
381
(3045414) Leukocytes [Presence] in Urine
26
108
2.49
4.30
1.6
1.6
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
148
1082
1.53
4.29
2.7
3.5
mmol/l
2.3
2.4
1.43
130
956
(3023368) Bacteria identified in Blood by Culture
127
900
1.56
4.22
4.9
4.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
39
195
2.09
4.21
3.1
2.6
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
145
1059
1.53
4.21
5.1
5.0
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
198
1543
1.49
4.21
5.4
5.4
%
8.3
8.6
0.63
187
1441
(3022217) INR in Platelet poor plasma by Coagulation assay
66
395
1.78
4.20
24.4
19.8
inr
1.7
1.3
1.37
13
61
(3006504) Eosinophils/100 leukocytes in Blood
197
1535
1.48
4.18
5.1
5.2
%
3.1
2.9
0.44
188
1426
(3022096) Basophils/100 leukocytes in Blood
192
1490
1.48
4.15
5.3
5.1
%
0.7
0.7
0.18
183
1384
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
114
791
1.58
4.15
2.2
1.9
mg/l
3.0
2.9
0.17
98
658
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
44
234
1.97
4.03
3.0
3.1
ml/min/173m2
67.9
64.1
0.19
14
96
(1761868) Lipid panel - Serum or Plasma
101
1421
0.63
4.02
2.8
2.8
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
100
677
1.60
4.02
2.4
2.4
e6/l
7.6
6.7
0.18
90
588
(3018010) Neutrophils/100 leukocytes in Blood
198
1555
1.47
3.99
5.3
5.0
%
57.4
57.0
0.21
188
1455
(3002030) Lymphocytes/100 leukocytes in Blood
201
1584
1.47
3.98
5.4
5.3
%
27.6
27.9
0.14
189
1473
(3013826) Glucose [Moles/volume] in Serum or Plasma
244
2000
1.45
3.91
5.4
4.5
mmol/l
6.8
6.8
0.19
227
1866
(3001122) Ferritin [Mass/volume] in Serum or Plasma
184
1430
1.47
3.89
2.9
2.4
ug/l
98.8
140.5
2.46
170
1326
(40768804) Tissue Pathology biopsy report
176
1359
1.47
3.84
2.4
2.0
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
38
197
2.01
3.75
1.8
1.7
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
14
45
3.18
3.68
1.0
1.1
u/ml
2.8
3.6
—
8
19
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
310
2676
1.46
3.67
4.1
3.7
pmol/l
14.6
14.7
0.45
282
2429
(3008401) Mugwort IgE Ab [Units/volume] in Serum
13
40
3.31
3.65
1.0
1.1
u/ml
3.1
1.4
—
6
13
(3000330) Specific gravity of Urine by Test strip
31
151
2.13
3.60
4.2
3.8
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
139
1037
1.48
3.56
4.0
3.9
mg/mmol
13.2
8.4
0.30
96
670
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
68
431
1.67
3.54
1.8
1.8
%
1.5
1.5
0.19
58
378
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
15
52
2.95
3.49
1.1
1.1
u/ml
0.4
3.8
—
7
15
(3003888) Timothy IgE Ab [Units/volume] in Serum
13
42
3.15
3.39
1.0
1.1
u/ml
16.4
11.4
—
6
15
(3000991) Gas panel - Venous blood
48
279
1.80
3.38
6.9
7.8
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
37
199
1.93
3.31
1.3
1.5
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
6
7
8.66
3.27
1.5
1.0
%
53.2
78.7
—
6
7
(3032080) INR in Blood by Coagulation assay
172
1355
1.42
3.26
7.0
7.6
inr
1.2
1.2
0.09
40
405
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
17
66
2.63
3.25
1.8
1.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
102
728
1.51
3.22
1.3
1.2
u/ml
1.9
1.7
0.06
22
192
(40768800) Prostate Pathology biopsy report
0
84
0.00
3.13
0.0
1.2
—
—
—
0
0
(4024509)
9
20
4.57
3.12
1.4
1.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
60
381
1.66
3.11
1.8
1.9
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
21
93
2.32
3.08
1.2
1.2
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
416
3867
1.61
2.97
18.8
14.6
umol/l
78.5
77.6
0.13
416
3867
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
360
3249
1.45
2.97
5.0
4.4
mu/l
1.9
2.3
0.57
339
2958
(4198724)
8
17
4.77
2.93
1.0
1.6
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
8
17
4.77
2.93
1.0
1.0
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
102
2.21
2.91
1.3
1.7
g/l
11.0
10.8
0.08
17
88
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
104
761
1.47
2.89
2.6
2.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
49
301
1.70
2.88
2.4
2.6
ug/l
7.7
8.4
0.12
41
263
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
59
381
1.63
2.87
1.7
1.9
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
21
97
2.22
2.81
1.9
1.4
ug/g
238.9
283.3
—
9
55
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
20
91
2.25
2.77
2.6
2.4
u/ml
0.2
0.4
2.40
14
55
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
77
535
1.52
2.75
1.8
1.9
—
—
—
0
0
(3008898) HLA-B27 [Presence]
16
66
2.47
2.74
1.1
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
58
378
1.61
2.73
1.7
2.4
ug/g
120.4
139.7
0.27
41
309
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
20
92
2.23
2.71
1.2
1.7
%
98.2
88.6
2.24
20
83
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
121
925
1.41
2.65
1.6
1.6
mmol/l
1.3
1.4
0.66
108
770
(3004588) Protein electrophoresis panel - Serum or Plasma
35
200
1.81
2.64
1.3
2.5
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
7
15
4.72
2.60
1.1
4.5
u/ml
1137.7
641.9
—
7
15
(3014111) Lactate [Moles/volume] in Serum or Plasma
48
302
1.66
2.60
6.3
6.9
mmol/l
1.3
1.4
0.24
48
290
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
163
1317
1.36
2.55
4.1
3.5
ng/l
25.8
70.6
0.96
106
892
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
122
940
1.40
2.55
3.5
3.0
ng/l
912.6
1281.5
1.44
105
792
(3026782) Osmolality of Urine
92
676
1.45
2.49
2.9
2.5
mosm/kgh2o
542.3
560.8
0.32
77
570
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
365
3342
1.40
2.45
6.3
5.4
mmol/mol
41.0
40.1
0.89
348
3083
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
9
28
3.26
2.32
1.1
1.0
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
12
47
2.59
2.28
1.1
1.1
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
46
297
1.61
2.27
2.3
2.2
g/l
0.2
0.2
0.15
39
280
(3009261) Glucose [Presence] in Urine by Test strip
197
1661
1.32
2.26
3.9
3.3
estimate
0.0
0.0
0.50
22
276
(3019150) Specific gravity of Urine by Refractometry
98
742
1.40
2.25
4.5
3.5
kg/l
1.0
1.0
0.07
14
97
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
39
242
1.67
2.24
4.8
3.5
ng/l
114.8
82.4
0.55
32
215
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
114
1.97
2.24
1.3
1.7
g/l
4.1
3.7
0.79
15
81
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
114
1.97
2.24
1.3
1.7
g/l
7.8
7.0
0.59
15
85
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
114
1.97
2.24
1.3
1.7
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
380
3520
1.40
2.24
4.5
4.2
mmol/l
6.1
6.0
1.07
364
3206
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
16
73
2.23
2.23
1.2
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
16
73
2.23
2.23
1.2
1.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
194
1642
1.31
2.13
3.9
3.3
estimate
0.0
0.0
0.00
22
286
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
12
49
2.49
2.12
1.2
1.2
—
1.1
—
0
5
(3000494) Fungus identified in Specimen by Culture
56
386
1.51
2.09
1.5
1.5
—
—
—
0
0
(4268621)
9
31
2.94
2.08
1.9
2.1
—
—
—
0
0
(1002224) Polysomnography panel
26
147
1.81
2.07
1.0
1.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
97
744
1.38
2.06
1.7
1.5
nmol/l
24.0
20.4
1.10
88
628
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
252
2217
1.29
2.04
3.1
2.9
—
—
—
0
0
(40761535) Cells panel - Urine sediment
41
266
1.59
2.00
4.0
3.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
56
391
1.49
1.98
6.5
7.7
mmol/l
1.1
1.4
0.28
47
298
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
11
45
2.48
1.94
1.0
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
11
45
2.48
1.94
1.2
2.2
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
17
85
2.04
1.92
1.2
2.0
%
178.4
185.4
0.13
17
80
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
13
58
2.28
1.92
1.6
1.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
193
1651
1.28
1.91
5.5
4.5
estimate
0.0
0.0
0.00
24
290
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
58
411
1.47
1.91
1.5
1.6
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
107
1.91
1.89
1.4
1.7
g/l
3.0
3.0
0.04
15
82
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
27
160
1.73
1.86
2.2
2.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
6
17
3.56
1.84
3.5
2.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
392
3683
1.37
1.84
5.3
4.7
mmol/l
2.8
2.8
0.60
370
3387
(3009542) Hematocrit [Volume Fraction] of Blood
359
3330
1.32
1.84
18.6
13.5
%
39.6
40.1
0.49
266
2422
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
29
177
1.68
1.81
4.3
10.7
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
8
29
2.79
1.80
1.1
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
400
3774
1.38
1.79
16.3
12.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
9
36
2.53
1.74
1.1
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
8
30
2.69
1.73
1.6
1.2
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
8
30
2.69
1.73
1.4
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
8
30
2.69
1.73
2.1
2.9
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
8
30
2.69
1.73
1.8
1.7
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
382
3590
1.33
1.67
4.4
4.2
mmol/l
1.4
1.5
0.57
365
3296
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
76
581
1.37
1.66
1.9
3.0
mmol/l
2.4
2.5
0.87
64
513
(3021589) Normoblasts [#/volume] in Blood
174
1493
1.26
1.63
7.3
8.2
e9/l
0.0
0.0
0.24
151
1208
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
384
3616
1.32
1.62
4.6
4.2
mmol/l
4.6
4.7
1.20
374
3353
(3007461) Platelets [#/volume] in Blood
425
4069
1.42
1.57
24.4
18.3
e9/l
254.8
248.6
1.00
420
3934
(3028707) Methadone [Presence] in Urine by Screen method
12
57
2.13
1.56
3.3
1.6
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
10
44
2.30
1.54
1.0
1.1
%
115.8
117.2
—
10
39
(3026361) Erythrocytes [#/volume] in Blood
425
4072
1.42
1.53
24.3
18.3
e12/l
4.5
4.5
2.29
418
3926
(3010813) Leukocytes [#/volume] in Blood
425
4072
1.42
1.53
24.4
18.3
e9/l
6.7
6.6
0.10
418
3924
(3007566) Smooth muscle Ab [Titer] in Serum
16
86
1.89
1.52
1.1
1.1
—
74.3
—
0
7
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
15
79
1.93
1.51
1.3
1.3
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
14
72
1.97
1.50
1.9
2.7
u/l
2.3
3797.4
—
5
28
(3002032) Base excess in Venous blood by calculation
44
311
1.46
1.50
5.3
3.3
mmol/l
1.6
1.9
0.25
39
238
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
13
66
2.00
1.44
1.3
1.3
—
37.9
—
0
6
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
16
3.15
1.44
1.0
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
9
39
2.33
1.43
2.0
1.3
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
30
198
1.55
1.41
2.4
3.2
pmol/l
4.6
4.5
0.34
30
180
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
36
248
1.49
1.40
1.2
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
20
119
1.71
1.40
2.6
1.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
12
60
2.03
1.39
1.0
1.0
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
21
127
1.68
1.39
1.0
1.0
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
30
199
1.54
1.38
1.2
1.2
u/ml
143.1
151.7
0.06
25
179
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
24
151
1.62
1.37
4.8
3.1
mmol/l
24.1
24.1
0.04
24
138
(3000764) Benzodiazepines [Presence] in Urine
20
120
1.70
1.36
2.7
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
20
120
1.70
1.36
2.6
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
20
120
1.70
1.36
2.6
1.6
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
13
68
1.94
1.34
1.4
1.1
—
—
—
0
0
(4306422)
9
42
2.16
1.34
1.1
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
49
363
1.39
1.31
3.7
4.3
ug/l
18.6
34.4
0.35
36
315
(3012095) Magnesium [Moles/volume] in Serum or Plasma
71
558
1.32
1.31
2.5
3.2
mmol/l
0.8
0.8
0.39
66
523
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
43
2.11
1.31
1.2
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
13
69
1.91
1.29
1.4
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
16
92
1.76
1.26
2.8
1.4
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
45
331
1.40
1.26
2.0
2.6
%
1.8
1.8
0.00
38
294
(3020191) Ethanol [Moles/volume] in Serum or Plasma
6
25
2.42
1.24
1.0
1.4
promille
2.5
1.1
—
6
17
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
364
3442
1.25
1.23
14.9
11.4
ml/min/173m2
82.9
81.6
0.57
309
2790
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
10
49
2.06
1.22
1.2
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
17
274
0.61
1.22
2.7
3.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
36
256
1.44
1.22
1.2
1.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
19
2.65
1.22
1.8
2.2
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
5
19
2.65
1.22
1.8
2.2
%
12.8
11.6
—
5
10
(3016879) Cocaine [Presence] in Urine
18
109
1.68
1.20
2.8
1.6
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
24
157
1.56
1.20
1.5
1.3
iu/l
34.2
32.5
0.11
24
136
(3004616) Nuclear Ab [Presence] in Serum
6
26
2.32
1.19
1.2
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
43
320
1.38
1.14
1.6
1.6
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
23
151
1.55
1.14
2.5
2.6
u/l
40.9
39.4
0.15
18
141
(40768443) Skin Pathology biopsy report
21
135
1.58
1.13
1.1
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
8
40
2.02
1.12
1.0
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
31
2.28
1.10
1.0
1.0
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
32
438
0.71
1.07
4.7
4.1
%
34.1
31.9
0.53
24
299
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
7
33
2.14
1.06
1.3
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
7
33
2.14
1.06
1.3
1.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
17
262
0.64
1.03
1.3
1.5
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
22
2.29
1.03
1.2
1.0
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
5
22
2.29
1.03
1.2
1.1
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
5
22
2.29
1.03
1.6
1.2
mmol/l
1.5
2.0
—
5
22
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
9
47
1.93
1.02
1.3
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
14
84
1.69
0.99
1.1
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
5
23
2.19
0.98
1.4
2.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
15
92
1.65
0.98
1.2
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
12
69
1.76
0.97
1.4
4.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
9
50
1.82
0.97
1.2
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
71
583
1.26
0.97
1.6
1.7
nmol/l
1152.4
1170.0
0.07
57
443
(3022145) Colonoscopy Study observation
48
375
1.31
0.96
1.3
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
15
93
1.63
0.95
1.2
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
21
142
1.50
0.94
3.0
3.4
u/ml
12.9
19823.8
0.59
16
127
(3037756) Immunofixation for Serum or Plasma
12
70
1.73
0.93
1.3
2.1
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
55
440
1.28
0.93
5.7
4.7
mmol/l
1.1
1.0
1.13
50
404
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
9
52
1.74
0.93
1.0
1.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
28
2.16
0.92
1.5
1.8
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
15
94
1.62
0.91
1.2
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
23
160
1.46
0.90
1.3
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
362
3463
1.19
0.87
4.0
3.8
mmol/l
1.3
1.3
0.49
343
3172
(3002256) Pathology report gross observation
55
445
1.27
0.86
1.2
1.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
16
104
1.56
0.85
1.1
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
13
80
1.64
0.85
2.0
1.8
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
6
31
1.95
0.84
1.2
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
27
198
1.39
0.82
1.6
1.5
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
6
33
1.83
0.79
1.3
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
13
195
0.66
0.74
1.8
1.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
9
55
1.65
0.74
1.2
1.2
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
5
25
2.01
0.73
1.0
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
9
56
1.62
0.72
1.0
1.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
63
531
1.21
0.70
1.5
1.4
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
7
41
1.72
0.70
1.4
1.0
—
—
—
0
0
(3000492) Spirometry study
40
321
1.27
0.69
1.2
1.5
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
7
43
1.64
0.67
2.3
1.7
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
16
111
1.46
0.66
1.1
1.1
—
1.5
—
0
12
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
15
103
1.47
0.65
1.5
1.5
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
7
44
1.60
0.65
2.4
2.2
%
13.2
13.0
—
7
44
(3047007) Chlamydophila sp Ab [Presence] in Serum
7
44
1.60
0.65
1.4
1.3
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
5
29
1.73
0.64
2.8
2.0
—
19.2
—
0
11
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
29
1.73
0.64
1.0
1.3
g/l
1.0
1.0
—
5
29
(40768806) Pleura Pathology biopsy report
5
29
1.73
0.64
1.0
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
30
379
0.78
0.64
1.5
1.8
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
30
1.67
0.61
1.2
1.9
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
8
51
1.58
0.60
2.0
2.8
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
12
80
1.51
0.60
1.5
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
61
522
1.19
0.60
1.7
1.7
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
6
35
1.72
0.58
1.0
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
6
36
1.67
0.57
1.0
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
37
303
1.24
0.56
1.4
1.9
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
38
313
1.23
0.55
1.5
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
18
134
1.36
0.53
2.7
2.9
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
10
66
1.53
0.53
1.3
1.6
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
28
224
1.27
0.52
1.4
1.2
—
—
—
0
0
(44790048)
6
40
1.51
0.51
1.2
1.5
—
—
—
0
0
(44806118)
6
40
1.51
0.51
1.2
1.5
—
—
—
0
0
(44790049)
6
40
1.51
0.51
1.2
1.5
—
—
—
0
0
(44790047)
6
40
1.51
0.51
1.2
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
17
127
1.35
0.50
1.9
1.7
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
30
244
1.24
0.49
1.7
3.0
e9/l
72.0
70.2
0.14
25
186
(3025159) Blasts/100 leukocytes in Blood
18
232
0.77
0.47
4.7
5.0
%
0.3
0.2
—
6
61
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
7
50
1.41
0.45
1.3
1.1
—
11.9
—
0
6
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
7
50
1.41
0.45
2.4
2.9
u/ml
6.5
8.3
—
7
45
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
13
95
1.38
0.44
1.3
3.5
—
2.9
—
0
9
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
9
128
0.70
0.44
1.6
1.5
—
—
—
0
0
(4010399)
32
267
1.21
0.43
1.7
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
8
56
1.44
0.42
2.0
1.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
5
32
1.57
0.42
1.4
2.3
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
16
0.00
0.41
0.0
1.7
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
79
714
1.13
0.41
1.6
1.7
pmol/l
140298889.1
22278482.8
0.39
67
597
(3013512) EKG study
106
975
1.11
0.41
4.0
3.7
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
(4062490)
5
34
1.48
0.40
1.2
1.4
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
0
18
0.00
0.40
0.0
31.3
—
126.2
—
0
13
(3020891) Body temperature
16
124
1.30
0.39
11.9
4.4
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
9
66
1.37
0.38
2.0
3.6
u/ml
14.1
114.2
—
9
61
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
21
170
1.25
0.38
4.1
2.4
%
0.6
0.7
0.22
21
164
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
22
180
1.23
0.36
2.6
2.8
u/ml
55.5
39.8
0.17
22
174
(3041096) Erythrocytes [Presence] in Urine by Automated
89
967
0.90
0.36
3.3
2.9
—
—
—
0
0
(3019060) Gas panel - Arterial blood
27
227
1.20
0.35
7.2
4.9
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
6
44
1.37
0.34
1.7
1.8
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
6
86
0.69
0.33
1.0
1.8
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
6
46
1.31
0.33
1.0
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
6
46
1.31
0.33
1.7
1.8
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
7
100
0.70
0.31
1.3
1.6
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
21
250
0.83
0.30
4.6
4.9
%
0.1
0.1
—
7
74
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
16
129
1.25
0.30
2.2
1.9
—
—
—
0
0
(40768793) Breast Pathology biopsy report
8
106
0.75
0.29
1.6
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
28
243
1.16
0.27
1.2
1.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
15
122
1.24
0.27
2.2
1.8
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
12
95
1.27
0.26
1.4
1.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
8
67
1.20
0.26
1.5
2.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
30
263
1.15
0.26
1.4
1.9
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
140
1333
1.07
0.26
4.2
3.4
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
22
190
1.17
0.23
2.5
2.5
e6/l
1.3
0.2
0.48
22
184
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
40
1.25
0.22
3.6
2.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
40
1.25
0.22
1.4
1.3
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
23
262
0.87
0.21
2.7
3.2
mmol/l
1.2
1.2
0.43
23
224
(3025941) Bacteria identified in Stool by Culture
21
182
1.16
0.21
1.3
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
5
42
1.19
0.21
3.4
2.9
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
5
42
1.19
0.21
1.4
1.3
nmol/l
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.2
—
2.5
—
0
5
(3020650) Glucose [Presence] in Urine
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
5
43
1.16
0.21
1.4
1.4
pmol/l
381.0
324.0
—
5
35
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
128
1225
1.06
0.21
4.1
4.6
ug/l
1.6
3.6
1.87
112
1090
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
0
14
0.00
0.20
0.0
1.6
—
625.6
—
0
8
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
51
1.18
0.19
1.7
1.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
100
952
1.06
0.19
1.3
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
21
184
1.15
0.19
1.0
1.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
35
319
1.10
0.18
2.5
2.9
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
36
392
0.91
0.17
1.3
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
10
82
1.22
0.17
1.2
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
105
1006
1.06
0.17
3.9
4.0
%
22.5
22.3
0.07
41
476
(3002179) Metamyelocytes/100 leukocytes in Blood
22
246
0.89
0.16
4.2
4.7
%
2.0
0.6
—
5
56
(1761482) Bacteria [#/volume] in Urine by Culture
12
101
1.19
0.16
7.8
4.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
8
68
1.18
0.16
1.4
1.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
47
438
1.08
0.16
1.3
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
78
742
1.06
0.16
3.4
4.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
55
517
1.07
0.15
1.5
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
10
83
1.21
0.15
2.7
1.9
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
7
89
0.78
0.14
2.3
2.5
mg/l
1.2
1.4
—
7
80
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
13
112
1.17
0.14
3.2
3.1
—
—
—
0
0
(4094501)
8
97
0.82
0.14
1.0
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
18
161
1.12
0.13
1.6
1.7
—
—
—
0
0
(3019225) pH of Specimen
34
316
1.08
0.13
5.9
4.2
—
—
—
0
0
(4034850)
10
116
0.86
0.12
24.2
8.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
5
46
1.09
0.09
1.8
3.2
%
56.6
56.3
—
5
46
(3023419) Bacteria identified in Sputum by Culture
5
47
1.06
0.09
1.6
2.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
43
409
1.06
0.09
11.6
6.9
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
5
48
1.04
0.09
1.4
1.8
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
22
237
0.92
0.09
1.1
1.2
iu/ml
154.8
165.7
—
9
99
(3012501) Base excess in Blood by calculation
5
62
0.80
0.08
5.2
3.5
mmol/l
2.4
2.6
—
5
47
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
7
66
1.06
0.08
1.6
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
8
77
1.04
0.07
1.5
1.8
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
8
90
0.89
0.07
1.1
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
74
721
1.03
0.06
2.5
2.9
ug/l
0.6
0.8
1.90
42
445
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
12
131
0.91
0.05
1.6
1.7
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
22
209
1.06
0.04
3.2
3.3
mmol/l
1.6
1.9
0.20
17
162
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
13
121
1.08
0.03
1.5
1.7
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
26
270
0.96
0.03
4.2
4.7
%
1.9
0.8
—
10
82
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
37
362
1.02
0.01
1.9
1.6
—
—
—
0
0
(4035726)
31
315
0.98
0.00
1.6
1.4
—
—
—
0
0
(3009343) pH of Capillary blood
22
216
1.02
0.00
3.3
3.3
—
7.4
—
0
21
(3022313) Gas panel - Capillary blood
17
167
1.02
0.00
3.5
3.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
89
892
1.00
0.00
4.3
3.4
estimate
0.0
0.0
0.50
21
283
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
88.3
—
0
7
(3013637) Mi-2 Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
3.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
7
0.00
0.00
0.0
4.6
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
7.3
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
9
0.00
0.00
0.0
7.8
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004451) EKG impression Narrative
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
9
0.00
0.00
0.0
7.6
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
29.8
—
0
7
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
9
0.00
0.00
0.0
1.6
—
1.9
—
0
9
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
8
82
0.98
0.00
1.5
1.7
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
0
6
0.00
0.00
0.0
1.0
—
24.5
—
0
6
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
42.8
—
0
5
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
8
84
0.95
0.00
1.3
1.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
8
83
0.96
0.00
2.8
2.8
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
1.7
—
0
6
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
58
0.86
0.00
1.2
1.3
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
5
53
0.94
0.00
1.0
1.1
—
11.2
—
0
13
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
5
49
1.02
0.00
1.2
1.3
nmol/l
0.1
0.5
—
5
42
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
7.5
—
0
6
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
6
59
1.02
0.00
3.5
2.6
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.4
—
112.5
—
0
5
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
0
8
0.00
-0.00
0.0
1.5
—
5.4
—
0
8
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
8
0.00
-0.00
0.0
3.0
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
8
0.00
-0.00
0.0
8.6
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint M13_CONTRACTUREJOINT and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_CONTRACTUREJOINT | 1.246 [1.0, 1.56] | 0.055 |
| Birth year | 0.997 [0.99, 1.01] | 0.451 |
During the follow-up period (1.1.1998 — 31.12.2019), 120 out of 1054 females with M13_CONTRACTUREJOINT died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_CONTRACTUREJOINT | 1.31 [1.07, 1.6] | 0.009 |
| Birth year | 0.987 [0.98, 1.0] | 0.006 |
During the follow-up period (1.1.1998 — 31.12.2019), 187 out of 1179 males with M13_CONTRACTUREJOINT died.
Mortality risk
Mortality risk for people of age
years, who have M13_CONTRACTUREJOINT.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.124% | 0.248% |
| 5 | 0.842% | 1.646% |
| 10 | 1.817% | 4.002% |
| 15 | 3.492% | 7.282% |
| 20 | 6.293% | 11.894% |
Relationships between endpoints
↥Index endpoint: M13_CONTRACTUREJOINT – Contracture of joint
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data